Home › Research › Topics › akt-gsk-3
akt-gsk-3
3 studies tagged akt-gsk-3, dated 2017-12-07 to 2020-02-05. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Weighted burden analysis of exome-sequenced late-onset Alzheimer's cases and controls provides further evidence for a role for PSEN1 and suggests involvement of the PI3K/Akt/GSK-3β and WNT signalling pathways 2020-02-05
- Attenuation of Aluminum Chloride-Induced Neuroinflammation and Caspase Activation Through the AKT/GSK-3β Pathway by Hesperidin in Wistar Rats 2018-04-23
- GLP-1 receptor agonists downregulate aberrant GnT-III expression in Alzheimer's disease models through the Akt/GSK-3β/β-catenin signaling 2017-12-07
Studies
3 studies carry this tag.
Date range
2017 to 2020
Top journals
- Annals of human genetics 1
- Neuropharmacology 1
- Neurotoxicity research 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Previous studies have implicated common and rare genetic variants as risk factors for late-onset Alzheimer's disease (LOAD).
-
Hesperidin, a flavanoglycone abundantly present in citrus fruits, is reported to have antioxidant, anti-inflammatory, and neuroprotective properties.
-
Alterations of glycoprotein glycans contribute to a wide variety of diseases.